Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Ferrari

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|May 12, 2010
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblastsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|April 29, 2014
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokineA Corrado, S M Ferrari, C Ferri, et al.
The British Journal of Surgery|July 14, 2006
Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomyA Antonelli, P Fallahi, M Rotondi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 2014
IP-10 in autoimmune thyroiditisI Ruffilli, S M Ferrari, M Colaci, et al.
European Review for Medical and Pharmacological Sciences|July 21, 2017
Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditisS M Ferrari, P Fallahi, F Di Bari, et al.
Nutrition and Cancer|April 25, 2019
Genotoxicity Evaluation of the Soybean Isoflavone Genistein in Human Papillary Thyroid Cancer Cells. Study of Its Potential Use in Thyroid Cancer TherapyS M Ferrari, A Antonelli, P Guidi, et al.
The British Journal of Dermatology|August 7, 2012
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblastsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|July 8, 2014
[CXCR3 and CXCL10 in autoimmune thyroiditis]I Ruffilli, S M Ferrari, M Colaci, et al.
Scandinavian Journal of Rheumatology|July 5, 2011
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controlsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|September 19, 2013
HCV-related autoimmune disorders in HCV chronic infectionS M Ferrari, P Fallahi, C Mancusi, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|May 12, 2010
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblastsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|April 29, 2014
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokineA Corrado, S M Ferrari, C Ferri, et al.
The British Journal of Surgery|July 14, 2006
Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomyA Antonelli, P Fallahi, M Rotondi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 2014
IP-10 in autoimmune thyroiditisI Ruffilli, S M Ferrari, M Colaci, et al.
European Review for Medical and Pharmacological Sciences|July 21, 2017
Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditisS M Ferrari, P Fallahi, F Di Bari, et al.
Nutrition and Cancer|April 25, 2019
Genotoxicity Evaluation of the Soybean Isoflavone Genistein in Human Papillary Thyroid Cancer Cells. Study of Its Potential Use in Thyroid Cancer TherapyS M Ferrari, A Antonelli, P Guidi, et al.
The British Journal of Dermatology|August 7, 2012
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblastsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|July 8, 2014
[CXCR3 and CXCL10 in autoimmune thyroiditis]I Ruffilli, S M Ferrari, M Colaci, et al.
Scandinavian Journal of Rheumatology|July 5, 2011
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controlsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|September 19, 2013
HCV-related autoimmune disorders in HCV chronic infectionS M Ferrari, P Fallahi, C Mancusi, et al.
Pageof 3